# Edgewise Therapeutics, Inc.: filings

EWTX · Nasdaq · CIK 1710072 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ewtx.md) · [Financials](/companies/ewtx/financials.md) · [Filings](/companies/ewtx/filings.md) · [Insiders](/companies/ewtx/insiders.md)

## Reports and events: 94 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 174, 8-K 49, 144 28, 3 22, SC 13G/A 20, 10-Q 17, SC 13G 12, SCHEDULE 13G/A 11, SC 13D/A 9, DEFA14A 7, S-8 7, 424B5 6, 10-K 5, 4/A 5, DEF 14A 5, SCHEDULE 13G 5, CORRESP 4, SC 13D 3, ARS 2, D 2, DRS/A 2, EFFECT 2, S-1/A 2, SCHEDULE 13D/A 2, UPLOAD 2, 424B3 1, 424B4 1, 8-A12B 1, 8-K/A 1, CERT 1, DRS 1, DRSLTR 1, PRE 14A 1, S-1 1, S-1MEF 1, S-3 1, S-3ASR 1, S-3MEF 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-06 | 12:05 ET | [10-Q](/filings/0001104659-26-091670.md) | Quarterly report, period 2026-06-30 | 0001104659-26-091670 |
| 2026-08-06 | 12:05 ET | [8-K](/filings/0001104659-26-091671.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-091671 |
| 2026-07-16 | 12:01 ET | [8-K/A](/filings/0001104659-26-084088.md) | 9.01 Financial statements and exhibits | 0001104659-26-084088 |
| 2026-07-13 | 12:37 ET | [8-K](/filings/0001104659-26-082902.md) | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-082902 |
| 2026-06-05 | 20:33 ET | [8-K](/filings/0001104659-26-071011.md) | 5.07 Shareholder vote results | 0001104659-26-071011 |
| 2026-06-01 | 12:51 ET | [8-K](/filings/0001193125-26-249951.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-249951 |
| 2026-05-07 | 13:20 ET | [8-K](/filings/0001104659-26-056783.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-056783 |
| 2026-05-07 | 12:09 ET | [10-Q](/filings/0001104659-26-056713.md) | Quarterly report, period 2026-03-31 | 0001104659-26-056713 |
| 2026-04-27 | 20:49 ET | [SCHEDULE 13D/A](/filings/0001388325-26-000014.md) | Ownership report, active investor, amended | 0001388325-26-000014 |
| 2026-04-23 | 20:06 ET | [DEF 14A](/filings/0001104659-26-047688.md) | Proxy statement, period 2026-06-04 | 0001104659-26-047688 |
| 2026-02-26 | 13:05 ET | [10-K](/filings/0001104659-26-020112.md) | Annual report, period 2025-12-31 | 0001104659-26-020112 |
| 2026-02-26 | 13:00 ET | [8-K](/filings/0001104659-26-020108.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-020108 |
| 2025-11-20 | 22:07 ET | [8-K](/filings/0001104659-25-114660.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-25-114660 |
| 2025-11-10 | 22:17 ET | [8-K](/filings/0001104659-25-109295.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-109295 |
| 2025-11-06 | 13:05 ET | [10-Q](/filings/0001104659-25-107427.md) | Quarterly report, period 2025-09-30 | 0001104659-25-107427 |
| 2025-11-06 | 13:00 ET | [8-K](/filings/0001104659-25-107419.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-107419 |
| 2025-08-07 | 12:05 ET | [10-Q](/filings/0001558370-25-010655.md) | Quarterly report, period 2025-06-30 | 0001558370-25-010655 |
| 2025-08-07 | 12:01 ET | [8-K](/filings/0001104659-25-074987.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-074987 |
| 2025-06-26 | 20:01 ET | [8-K](/filings/0001104659-25-063028.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-063028 |
| 2025-05-12 | 23:13 ET | [SCHEDULE 13D/A](/filings/0000947871-25-000490.md) | Ownership report, active investor, amended | 0000947871-25-000490 |
| 2025-05-08 | 12:05 ET | [10-Q](/filings/0001558370-25-006857.md) | Quarterly report, period 2025-03-31 | 0001558370-25-006857 |
| 2025-05-08 | 12:00 ET | [8-K](/filings/0001104659-25-045896.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-045896 |
| 2025-04-29 | 20:15 ET | [DEF 14A](/filings/0001558370-25-005845.md) | Proxy statement, period 2025-06-13 | 0001558370-25-005845 |
| 2025-04-02 | 10:29 ET | [8-K](/filings/0001104659-25-030870.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-030870 |
| 2025-04-02 | 10:06 ET | [8-K](/filings/0001104659-25-030839.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-030839 |
| 2025-03-03 | 13:05 ET | [10-K](/filings/0001558370-25-002006.md) | Annual report, period 2024-12-31 | 0001558370-25-002006 |
| 2025-03-03 | 13:00 ET | [8-K](/filings/0001104659-25-019498.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-019498 |
| 2025-01-22 | 13:20 ET | [8-K](/filings/0001104659-25-005075.md) | 5.02 Departure or appointment of officers or directors | 0001104659-25-005075 |
| 2024-12-16 | 22:25 ET | [8-K](/filings/0001104659-24-129001.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-129001 |
| 2024-11-12 | 22:23 ET | [SC 13D/A](/filings/0000947871-24-000874.md) | Ownership report, active investor, amended | 0000947871-24-000874 |
| 2024-11-07 | 13:07 ET | [10-Q](/filings/0001558370-24-014762.md) | Quarterly report, period 2024-09-30 | 0001558370-24-014762 |
| 2024-11-07 | 13:00 ET | [8-K](/filings/0001104659-24-115077.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-115077 |
| 2024-09-23 | 01:20 ET | [SC 13D/A](/filings/0001193125-24-223906.md) | Ownership report, active investor, amended | 0001193125-24-223906 |
| 2024-08-12 | 21:07 ET | [8-K](/filings/0001104659-24-088426.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-24-088426 |
| 2024-08-08 | 12:06 ET | [10-Q](/filings/0001558370-24-011477.md) | Quarterly report, period 2024-06-30 | 0001558370-24-011477 |
| 2024-08-08 | 12:00 ET | [8-K](/filings/0001104659-24-087031.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-087031 |
| 2024-06-11 | 01:09 ET | [8-K](/filings/0001104659-24-070114.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-24-070114 |
| 2024-05-10 | 13:10 ET | [8-K](/filings/0001104659-24-059674.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001104659-24-059674 |
| 2024-05-09 | 12:06 ET | [10-Q](/filings/0001544784-24-000056.md) | Quarterly report, period 2024-03-31 | 0001544784-24-000056 |
| 2024-05-09 | 12:00 ET | [8-K](/filings/0001104659-24-059136.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-059136 |
| 2024-05-07 | 13:14 ET | [8-K](/filings/0001104659-24-057783.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-24-057783 |
| 2024-04-26 | 20:10 ET | [DEF 14A](/filings/0001558370-24-005905.md) | Proxy statement, period 2024-06-07 | 0001558370-24-005905 |
| 2024-02-22 | 13:07 ET | [10-K](/filings/0001558370-24-001467.md) | Annual report, period 2023-12-31 | 0001558370-24-001467 |
| 2024-02-22 | 13:00 ET | [8-K](/filings/0001104659-24-026336.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-026336 |
| 2024-01-25 | 21:26 ET | [SC 13D/A](/filings/0001193125-24-015434.md) | Ownership report, active investor, amended | 0001193125-24-015434 |
| 2024-01-25 | 21:25 ET | [SC 13D/A](/filings/0000947871-24-000068.md) | Ownership report, active investor, amended | 0000947871-24-000068 |
| 2024-01-19 | 13:44 ET | [8-K](/filings/0001104659-24-005031.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-005031 |
| 2024-01-19 | 11:05 ET | [8-K](/filings/0001104659-24-004966.md) | 2.02 Results of operations; 8.01 Other events | 0001104659-24-004966 |
| 2023-11-09 | 13:05 ET | [10-Q](/filings/0001558370-23-018427.md) | Quarterly report, period 2023-09-30 | 0001558370-23-018427 |
| 2023-11-09 | 13:00 ET | [8-K](/filings/0001157523-23-001700.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001157523-23-001700 |

Page 1 of 2. [Older](/companies/ewtx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.